Story

Alphabet Options Market Prices 5.1% Post-Earnings Stock Move

ENTHMSVIIDZHZH-TWJAKOHI
Jul 15, 20261 min read
Alphabet Options Market Prices 5.1% Post-Earnings Stock Move

Summary

The options market is pricing in a potential 5.1% swing for Alphabet's stock following its earnings report on July 22, according to Bloomberg data. Historically, the stock has exceeded the market's implied move in five of the last eight quarters.

Text size
Background

The options market is anticipating a 5.1% move in either direction for Alphabet Inc. (GOOGL) shares following the company's upcoming earnings release on July 22, according to data compiled by Bloomberg.

Market Expectations

This implied move is derived from the pricing of options contracts and reflects traders' expectations for stock volatility surrounding the earnings event. It serves as a market-based forecast of the potential magnitude of the stock's reaction, but not its direction. Alphabet is scheduled to report its financial results after the market closes on July 22.

Historical Volatility vs. Projections

An analysis of past performance shows that Alphabet's stock has often been more volatile than the options market predicted. The shares have exceeded the implied post-earnings move in five of the last eight reporting periods, suggesting a tendency for significant market reactions to the company's quarterly results.

Sample IUX Markets – In-articleAd

Notable past movements include:

  • April 2026: The stock surged 15.8%, far exceeding the 4.5% implied move.
  • October 2025: Shares climbed 12.4% against an expected 6.4% move.
  • July 2024: Shares fell 7.5%, a larger move than the 5.7% priced in by options traders.

Conversely, the stock has also underperformed expectations on three occasions in the last eight quarters. Following the February 2026 report, the stock fell just 1.0% when a 5.3% move was priced in.

Read next

More on Stocks
Shenzhen-Listed Jingxin Pharmaceutical Refiles for Hong Kong IPO

Stocks

Shenzhen-Listed Jingxin Pharmaceutical Refiles for Hong Kong IPO

Sep 20, 2026

Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ) has resubmitted its application for a main board listing on the Hong Kong Stock Exchange, aiming to secure a dual listing to access international capital. The company specializes in drugs for central nervous system and cardiovascular diseases.

Back to latest news

LATEST